A detailed history of Kopp Family Office, LLC transactions in Vericel Corp stock. As of the latest transaction made, Kopp Family Office, LLC holds 457,678 shares of VCEL stock, worth $20.3 Million. This represents 13.03% of its overall portfolio holdings.

Number of Shares
457,678
Previous 457,615 0.01%
Holding current value
$20.3 Million
Previous $23.8 Million 11.79%
% of portfolio
13.03%
Previous 13.6%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$41.71 - $52.9 $2,627 - $3,332
63 Added 0.01%
457,678 $21 Million
Q1 2024

Jun 17, 2024

SELL
$32.52 - $52.33 $58,536 - $94,194
-1,800 Reduced 0.39%
457,615 $23.8 Million
Q3 2023

Nov 14, 2023

SELL
$31.69 - $39.25 $507,040 - $628,000
-16,000 Reduced 3.37%
459,415 $15.4 Million
Q2 2023

Aug 14, 2023

SELL
$29.0 - $38.37 $2.61 Million - $3.45 Million
-89,903 Reduced 15.9%
475,415 $17.9 Million
Q1 2023

May 15, 2023

BUY
$23.85 - $31.34 $164,684 - $216,402
6,905 Added 1.24%
565,318 $16.6 Million
Q4 2022

Feb 14, 2023

BUY
$17.65 - $27.37 $96,192 - $149,166
5,450 Added 0.99%
558,413 $14.7 Million
Q3 2022

Nov 14, 2022

SELL
$22.62 - $32.54 $226 - $325
-10 Reduced -0.0%
552,963 $12.8 Million
Q2 2022

Aug 16, 2022

BUY
$22.88 - $39.45 $1,098 - $1,893
48 Added 0.01%
552,973 $13.9 Million
Q1 2022

May 16, 2022

BUY
$31.69 - $43.29 $305,808 - $417,748
9,650 Added 1.78%
552,925 $21.1 Million
Q4 2021

Feb 15, 2022

SELL
$35.2 - $52.6 $228,800 - $341,900
-6,500 Reduced 1.18%
543,275 $21.4 Million
Q3 2021

Nov 16, 2021

BUY
$46.35 - $59.75 $477,405 - $615,425
10,300 Added 1.91%
549,775 $26.8 Million
Q2 2021

Aug 16, 2021

SELL
$47.2 - $67.81 $1.63 Million - $2.35 Million
-34,605 Reduced 6.03%
539,475 $28.3 Million
Q1 2021

May 17, 2021

SELL
$30.93 - $59.48 $17.8 Million - $34.3 Million
-576,655 Reduced 50.11%
574,080 $31.9 Million
Q3 2020

Nov 16, 2020

BUY
$14.68 - $19.12 $1.01 Million - $1.31 Million
68,580 Added 6.34%
1,150,735 $21.3 Million
Q2 2020

Aug 17, 2020

SELL
$8.5 - $15.82 $373 Million - $694 Million
-43,880,845 Reduced 97.59%
1,082,155 $15 Million
Q2 2020

Aug 14, 2020

BUY
$8.5 - $15.82 $376 Million - $699 Million
44,214,745 Added 5909.05%
44,963,000 $15 Million
Q1 2020

May 15, 2020

BUY
$7.25 - $19.22 $4.7 Million - $12.5 Million
648,455 Added 649.75%
748,255 $6.86 Million
Q4 2019

Feb 14, 2020

BUY
$13.77 - $19.2 $1.37 Million - $1.92 Million
99,800 New
99,800 $1.74 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.09B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Kopp Family Office, LLC Portfolio

Follow Kopp Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kopp Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kopp Family Office, LLC with notifications on news.